Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib Dosing Schedules + Gem/Carbo in mTNBC
NCT01045304Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of iniparib in triple-negative breast cancer (TNBC), sponsored by Sanofi. Started Feb 2010; status: completed.
02
Drugs
iniparib
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01045304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045304.